Advertisement

Sepracor Inc. Company Profile

16:16 EDT 23rd May 2013 | BioPortfolio

Sepracor Inc., an indirect, wholly-owned subsidiary of Dainippon Sumitomo Pharma Co., Ltd., is a research-based pharmaceutical company dedicated to treating and preventing human disease by discovering, developing and commercializing innovative pharmaceutical products that are directed toward serving large and growing markets and unmet medical needs.


News Articles [ 9 Associated News Articles listed on BioPortfolio]

Sunovion Layoffs?

Unfortunately, I'm hearing talk of a big layoff at Sunovion (neé Sepracor). Anyone have any details? Their business has been in developing trouble for some time now. . .

Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovion's Brovana Product

PITTSBURGH, May 24, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that Mylan Specialty L.P., f/k/a Dey Pharma, L.P., has entered into an agreement with Sunovion Pharmaceuticals Inc., f...

Sunovion Targets Respiratory Drug in $430M Deal for Elevation Pharma

Sticking with a lean business model has paid off big for San Diego’s Elevation Pharmaceuticals, which has agreed to a buyout offer from Marlborough, MA-based Sunovion Pharmaceuticals that could even...

Mylan Announces Settlement Agreement in Litigation Relating to its Generic Xopenex

Mylan Inc. today announced that Mylan Specialty L.P., f/k/a Dey Pharma, L.P., has entered into a settlement agreement with Sunovion Pharmaceuticals Inc., f/k/a Sepracor Inc., that will resolve the par...

Mylan settles patent litigation relating to Sunovion's Brovana product

Mylan Inc., a global pharmaceutical company committed to setting new standards in healthcare, announced that Mylan Specialty L.P., f/k/a Dey Pharma, LP, has entered into an agreement with Sunovion Pha...

Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovion's Brovana® Product

PITTSBURGH, May 24, 2012 /- Mylan Inc. (Nasdaq: MYL ) today announced that Mylan Specialty L.P., f/k/a Dey Pharma, L.P., has entered into an agreement with Sunovion Pharmaceuticals Inc., f/k/a...

Auxilium CEO Goes Against Type, Buying Instead of Selling

CHESTERBROOK, Penn. (TheStreet) -- Adrian Adams was named chief executive officer of Auxilium Pharmaceuticals in December 2011 with the reputation as a great salesman. His prior CEO posts at Inspire...

Blend Therapeutics Appoints Mark Iwicki as Chief Executive Officer

Blend Therapeutics, Inc., a biopharmaceutical company discovering new classes of medicines to treat debilitating diseases, announced today the appointment of Mark Iwicki as...

Drugs and Medications [ 4 Associated Drugs and Medications listed on BioPortfolio]

Xopenex [Rebel Distributors Corp]

Xopenex (levalbuterol HCl) Inhalation Solution 0.31 mg*, 0.63 mg*, 1.25 mg*

Xopenex hfa [Sunovion Pharmaceuticals Inc.]

XOPENEX HFA (levalbuterol tartrate) Inhalation Aerosol

Xopenex [Sunovion Pharmaceuticals Inc.]

Xopenex (levalbuterol HCl) Inhalation Solution 0.31 mg*, 0.63 mg*, 1.25 mg*

Alvesco [Sunovion Pharmaceuticals Inc.]

These highlights do not include all the information needed to use ALVESCO safely and effectively. See full prescribing information for ALVESCO. ALVESCO (ciclesonide) Inhalation Aerosol 80 mcg, 160 mcg...

PubMed Articles [ 1 Associated PubMed Articles listed on BioPortfolio]

Design, synthesis, and structure-activity relationships of novel bicyclic azole-amines as negative allosteric modulators of metabotropic glutamate receptor 5.

A novel series of diaryl bicyclic azole-amines that are potent selective negative modulators of metabotropic glutamate receptor 5 (mGluR5) were identified through rational design. An initial hit compo...

Clinical Trials [0 Results]

None

Companies [ 5 Associated Companies listed on BioPortfolio]

HemaSure Incorporated

HemaSure Inc. is a wholly-owned subsidiary of Sepracor Inc. ("Sepracor"). Sepracor transferred to the Hemasure its technology relating to the manufacture, use and sale of medical devices for the...

Sepracor Inc.

Sepracor Inc., an indirect, wholly-owned subsidiary of Dainippon Sumitomo Pharma Co., Ltd., is a research-based pharmaceutical company dedicated to treating and preventing human d...

Dainippon Sumitomo Pharma America, Inc.

Dainippon Sumitomo Pharma America, Inc. (DSPA) located in Fort Lee, N.J., is a subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP). On April 1, 2010, DSP's two North American operations - DSPA and...

Sepracor

Sepracor Incorporated is a specialty pharmaceutical company focused on the cost-effective development of safer, purerand more effective drugs that are improved versions of widely-prescribed pharmaceut...

Allergy and Asthma Associates

Allergy and Asthma Associates is one of the oldest allergy-asthma practices in the Pacific Northwest starting in 1938 by James Stroh, Sr. Drs. James Stroh, Jr and Rick Lane Johnson joined Dr. Stroh in...

More Information about "Sepracor Inc." on BioPortfolio

We have published hundreds of Sepracor Inc. news stories on BioPortfolio along with dozens of Sepracor Inc. Clinical Trials and PubMed Articles about Sepracor Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sepracor Inc. Companies in our database. You can also find out about relevant Sepracor Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement